We feel privileged to announce two eminent dermatologists from Europe Professor Harald Kittler (Vienna) and Professor Iris Zalaudek (Graz) amongst the significant line-up of international and local speakers. They are both very familiar with our practice in Australia and they understand what primary care doctors in Australia need to know about, need to think about, and need to be aware of.
The summit will include more international and Australian experts to help deliver the latest clinical content on skin cancer prevention, diagnosis and treatment. We are hard at work finalising the program and speaker list so please check back often for updated information.
Professor at the Department of Dermatology, Medical University of Vienna, Austria
Research Director of the Non-Melanoma Skin Cancer Unit. Division of Dermatology and Venerology, Medical University of Graz, Austria
Dr Iris Zalaudek is a Board-certiﬁed dermatologist and Director of the Non-Melanoma and Orphan Skin Cancer Unit at the Division of Dermatology of the Medical University of Graz, Austria. Since 2016, she has been President of the International Dermoscopy Society.
Her main research ﬁelds are related to dermato-oncology and include non-invasive skin imaging techniques, as well as topical and systemic treatment of skin cancer. Moreover, she is engaged in the development of modern teaching methods such as online distant courses and tele-dermatologic services. She is Director of the Master of Science program entitled "Dermoscopy and Preventive Dermato-Oncology" of the Medical University of Graz, Austria.
Iris has published more than 450 articles, of which 358 (267 full papers) have been cited in PubMed. Her combined publications have received an impact factor of 1003 and a h-index value of 36 (by April 2017). In 2003 her work was awarded by the Hans-Weitgasser Price from the Styrian Association of Dermatologists and in 2008 she was awarded the Best Researcher of the Medical University of Graz, Austria.
MBBS PhD FSCCA
Associate Professor and Director MMed (Skin Cancer) Program School of Medicine, The University of Queensland
Associate Professor Cliff Rosendahl currently works in Brisbane, Australia as a primary care practitioner with a special interest in skin cancer. He also has an interest in research as the clinical developer and Director of the Skin Cancer Audit Research Database (SCARD). His other main area of research has been in evaluating dermatoscopic clues for the diagnosis of both pigmented and non-pigmented skin malignancy in collaboration with colleagues at The University of Queensland, Australia and the Medical University of Vienna, Austria.
Cliff has a strong commitment to teaching with a view to achieving an improvement in both the detection and management of skin cancer in Australasia and internationally.
MBBS (Hons), MMed, FACRRM, FSSCA
Skin Cancer Physician at Milton Skin Cancer Clinic, NSW South Coast, Australia
Mayne Professor and Head, Discipline of Surgery, The University of Queensland
Director, Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital
Chairman, Queensland Melanoma Project
Director, Melanoma Patients Australia
Executive, Section of Academic Surgery, Royal Australasian College of Surgeons
Dr Mark Smithers is a surgeon associated with the multi-disciplinary Melanoma Clinic at the Princess Alexandra Hospital, managing patients with all stages of the disease. He is actively researching the epidemiological aspects (in collaboration with QIMR Berghofer) and surgical management of melanoma (NH&MRC, UQ Cancer Research fund, Cancer Council of Queensland).
Mark is also the principle investigator on multi-centre NIH sponsored and industry lead phase I, II and III trials for patients with advanced stages of melanoma.
Associate Professor of Dermatology, The University of Queensland School of Medicine
MBChB MSc MD PhD DSc MRCP FRACGP FACRRM FAFPHM
Deputy Vice Chancellor, Macquarie University, Sydney
Founder and CEO of HealthCert International
Born in Australia, Paul has almost 20 years' work experience with a focus on skin cancer. He was a pioneer of the original subspecialised skin cancer business model and owns the National Skin Cancer Centres, a network of dedicated skin cancer referral centres and training facilities across several states of Australia.
In 2006, Paul founded HealthCert, a global organisation dedicated to changing the lives of doctors and patients in the area of skin cancer medicine. With the vision of a world where nobody dies from skin cancer, the company operates in ﬁve countries through three distinct business units: Medical Education, Skin Cancer Centres and Tele-Dermatology services. With more than 8,000 GPs trained across 15 countries, Paul has taken HealthCert to become the largest provider of university-assured education for medical professionals in skin cancer and various other medical ﬁelds.
In 2016, Paul founded the Skin Cancer Institute, a global multidisciplinary not-for-proﬁt organisation, focusing on research, awareness and a better availability and delivery of diagnosis and treatment in skin cancer medicine.
Radiation Oncologist, Genesis Cancer Care Queensland
Professor for Cutaneous Oncology, Principal Research Fellow, The University of Queensland
Professor Nikolas Haass is a clinician scientist specialising in skin cancer. His interests are the understanding of
(1) cell-cell and cell-matrix interactions of melanoma with its microenvironment;
(2) signalling pathways in melanoma, particularly with regards to identifying novel melanoma therapies; and
(3) the characterisation of the dynamic heterogeneity of melanoma cell subpopulations. Using cutting-edge microscopy technology, including real-me cell cycle and cell death imaging in three-dimensional cell culture and in vivo models, his team investigates the biology of tumour heterogeneity with the goal to develop novel therapeutic approaches by simultaneously targeting diﬀerent melanoma subpopulations.
Founding member of the Australasian College of Skin Cancer Medicine Skin Cancer
Doctor at Peninsula Skin Cancer Centre, Victoria
Postdoctoral Research Oﬃcer, The University of Queensland Diamantina Institute, Faculty of Medicine
Professor for Public Health and Health Services, Oncology and Carcinogenesis, Queensland University of Technology
Professor Monika Janda is a Principal Research Fellow and leads the Health Determinants and Health Systems Theme at The Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT). Her research is funded through an NHMRC Career Development Fellowship Level II. Monika is a health psychologist with a research background in cancer prevention and quality of life research. She was a research fellow for the Melanoma Screening trial with the Cancer Council Queensland before joining QUT in 2006.
Monika has two main research interests:
- prevention and early detection of cancer (particularly melanoma); and
- improving clinical and supportive care for cancer patients (particularly gynaecological cancers).
During the past ﬁve years, she has had a strong research focus on improving the early detection of melanoma using telehealth methods such as mobile teledermoscopy and enhanced skin self-examination.
PhD. NHMRC Research Fellow, Dermatology Research Centre, Translational Research Institute, Brisbane
Dr Mitchell Stark is a Research Fellow with the Dermatology Research Centre (The University of Queensland) and has been actively working in the ﬁeld of melanoma research for 17 years.
Throughout his career he has authored over 50 publications relating to the greater understanding of the biology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. More recently, Mitchell’s research focus has been the identiﬁcation of ‘melanoma-speciﬁc’ microRNA biomarkers that can be measured via a simple blood test, which in the future may be potentially useful for clinical management of disease. In addition to microRNA signatures, one of his ongoing projects is studying the molecular hallmarks of growing and involuting naevi – the key to early detection of primary and invasive melanoma.
Senior lecturer (Skin Cancer) & Course Coordinator MMed (Skin Cancer), The University of Queensland
MBBS MMed PhD FSCCA
Senior lecturer MMed (Skin Cancer) Program School of Medicine, The University of Queensland Associate Professor of Skin Cancer Medicine, University of New South Wales
Associate Professor John Pyne was conferred with a Master of Medicine at The University of Queensland, then held a position of Program Director for The University of Queensland Skin Cancer Masters from 2007 until 2013. The thesis for John’s PhD was on the correlations between dermatoscopy and histopathology for BCC and SCC. He is also a past President and Fellow of the Skin Cancer College of Australasia.
John has a main interest in the optical imaging of early primary non-lymphoid cutaneous malignancy and correlations with histopathology. He is currently investigating surgical margins in management of these cancers. John has teaching appointments at The Universities of Queensland, New South Wales and Western Sydney.
MBBS, MMed (Skin Cancer)
Senior Lecturer, The University of Queensland
Director at Newcastle Skin Check, Charlestown NSW
Chair of the Clinical Senate at Health Department of Western Australia
MBBS, FRACS, FRACS
Plastic and Reconstructive Surgeon, Senior Plastic Surgeon at the Melanoma Clinic at Princess Alexandra Hospital
The University of Queensland
Dr Claudia Curchin
Junior Doctor Research Fellowship recipient and Fellow of the Australasian College of Dermatologists
Dr Isabelle Jonsson-Lear
MB Ch B FRACGP FACRRM FACSCM FSCCA
M.Med in Primary Skin Cancer Medicine
Senior Lecturer, Skin Cancer, The University of Queensland
General practitioner at Haly Health & Skin Medical Centre, Queensland, Australia
Director, Skin Cancer College Australasia
Dr Scott Arnold
Senior Lecturer (Skin Cancer), The University of Queensland, Australia
Dr Candice Deans